Sex, n (%)
| |
Women
|
910 (41.2)
|
Men
|
1296 (58.8)
|
Age at diagnosis, n (%)
| |
33 ≤–< 55 years
|
238 (10.8)
|
55 ≤–< 65 years
|
479 (21.7)
|
65 ≤–< 75 years
|
776 (35.2)
|
75 ≤–≤ 96 years
|
713 (32.3)
|
Tumor stage, n (%)*
| |
I
|
400 (18.2)
|
II
|
760 (34.6)
|
III
|
726 (33.1)
|
IV
|
309 (14.1)
|
Leukocyte composition, Median (IQR)#
| |
CD4 + T cells
|
0.12 (0.07, 0.17)
|
CD8 + T cells
|
0.03 (0.004, 0.06)
|
NK cells
|
0.07 (0.04, 0.11)
|
B cells
|
0.04 (0.03, 0.06)
|
Monocytes
|
0.08 (0.06, 0.10)
|
Granulocytes
|
0.65 (0.56, 0.74)
|
Charlson comorbidity index, n (%)
| |
0 (no comorbidity)
|
1282 (58.1)
|
1 (mild comorbidity)
|
479 (21.7)
|
2 (moderate comorbidity)
|
264 (12.0)
|
3+ (severe comorbidity)
|
182 (8.2)
|
Tumor sub-site, n (%)*
| |
Proximal colon†
|
796 (36.1)
|
Distal colon‡
|
738 (33.5)
|
Rectum
|
670 (30.4)
|
BMI at diagnosis, n (%)*
|
–
|
< 25 kg/m2
|
834 (38.0)
|
25 ≤–< 30 kg/m2
|
932 (42.4)
|
≥ 30 kg/m2
|
430 (19.6)
|
Alcohol consumption, n (%)*
|
–
|
Abstainer
|
380 (17.3)
|
Female: < 20 g/day; Male: < 40 g/day
|
1559 (70.9)
|
Female: ≥ 20 g/day; Male: ≥ 40 g/day
|
260 (11.8)
|
Smoking status, n (%)*
| |
Never
|
907 (41.1)
|
Former
|
948 (43.0)
|
Current
|
350 (15.9)
|